ClearVue Technologies has exceeded its $1 million target in a Share Purchase Plan, raising $1.29 million and issuing over 14.6 million shares with free attaching options pending shareholder approval.
- SPP oversubscribed, raising $1.29 million
- 14.67 million shares issued at $0.088 each
- 1-for-1 free attaching options exercisable at $0.115
- Options subject to shareholder approval at upcoming meeting
- CEO cites strong shareholder confidence in strategy
Oversubscribed Share Purchase Plan Boosts Capital
ClearVue Technologies Limited (ASX:CPV) has successfully closed its latest Share Purchase Plan (SPP) with applications exceeding the initial $1 million target, raising $1.29 million. The company issued 14,670,426 shares at $0.088 each, reflecting the lower of the set price or a 2.5% discount to the volume-weighted average price (VWAP) over the five trading days leading up to the close.
Free Attaching Options Pending Shareholder Approval
Alongside the shares, ClearVue is offering a 1-for-1 free attaching option exercisable at $0.115, with a three-year expiry. These options will only be issued following shareholder approval under ASX Listing Rule 7.1 at an upcoming General Meeting, the date of which remains to be confirmed. The board exercised its discretion to accept oversubscriptions, signalling confidence in the capital raise’s support.
CEO Highlights Shareholder Confidence Amid Growth Strategy
CEO and Managing Director Doug Hunt emphasised the strong backing from both existing and new investors as a clear endorsement of ClearVue’s strategic direction. He underscored the company’s focus on advancing its global project pipeline, product certification efforts, and delivering shareholder value over the long term.
Capital Raise Supports Renewable Building Materials Innovation
ClearVue specialises in integrating solar technology into building façades and rooftops, producing renewable energy while maintaining glass transparency. The funds raised through this SPP will bolster the company’s capacity to execute projects and potentially accelerate commercialisation of its patented solar glass solutions. This follows recent strides in product certification and board strengthening, including the appointment of Professor Rebecca Yang, a recognised expert in building-integrated photovoltaics.
Bottom Line?
The oversubscribed SPP strengthens ClearVue’s balance sheet, but the timing of option issuance hinges on shareholder approval, which could influence near-term capital structure and investor sentiment.
Questions in the middle?
- When will the General Meeting for option approval be scheduled?
- How will the additional capital be allocated across ClearVue’s project pipeline?
- What impact might the option issuance have on share dilution and trading liquidity?